Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V
- PMID: 8900278
- DOI: 10.1038/384066a0
Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V
Abstract
Coagulation factor V is a critical cofactor for the activation of prothrombin to thrombin, the penultimate step in the generation of a fibrin blood clot. Genetic deficiency of factor V results in a congenital bleeding disorder (parahaemophilia), whereas inheritance of a mutation rendering factor V resistant to inactivation is an important risk factor for thrombosis. We report here that approximately half of homozygous embryos deficient in factor V (Fv-/-), which have been generated by gene targeting, die at embryonic day (E) 9-10, possibly as a result of an abnormality in the yolk-sac vasculature. The remaining Fv-/- mice progress normally to term, but die from massive haemorrhage within 2 hours of birth. Considered together with the milder phenotypes generally associated with deficiencies of other clotting factors, our findings demonstrate the primary role of the common coagulation pathway and the absolute requirement for functional factor V for prothrombinase activity. They also provide direct evidence for the existence of other critical haemostatic functions for thrombin in addition to fibrin clot formation, and identify a previously unrecognized role for the coagulation system in early mammalian development.
Similar articles
-
Rescue of fatal neonatal hemorrhage in factor V deficient mice by low level transgene expression.Thromb Haemost. 2000 Jan;83(1):70-7. Thromb Haemost. 2000. PMID: 10669158
-
A role for thrombin receptor signaling in endothelial cells during embryonic development.Science. 2001 Aug 31;293(5535):1666-70. doi: 10.1126/science.1061259. Science. 2001. PMID: 11533492
-
Factor V deficiency.Semin Thromb Hemost. 2009 Jun;35(4):382-9. doi: 10.1055/s-0029-1225760. Epub 2009 Jul 13. Semin Thromb Hemost. 2009. PMID: 19598066 Review.
-
Advances in understanding the bleeding diathesis in factor V deficiency.Br J Haematol. 2009 Jun;146(1):17-26. doi: 10.1111/j.1365-2141.2009.07708.x. Epub 2009 Apr 27. Br J Haematol. 2009. PMID: 19438479 Review.
-
Coagulation factor V.Int J Biochem Cell Biol. 2004 Aug;36(8):1393-9. doi: 10.1016/j.biocel.2003.08.002. Int J Biochem Cell Biol. 2004. PMID: 15147718 Review.
Cited by
-
Thrombus stability explains the factor V Leiden paradox: a mouse model.Blood Adv. 2019 Nov 12;3(21):3375-3378. doi: 10.1182/bloodadvances.2019031112. Blood Adv. 2019. PMID: 31698465 Free PMC article.
-
Analysis of factor V in zebrafish demonstrates minimal levels needed for early hemostasis.Blood Adv. 2019 Jun 11;3(11):1670-1680. doi: 10.1182/bloodadvances.2018029066. Blood Adv. 2019. PMID: 31167819 Free PMC article.
-
Blood coagulation factors V and VIII: Molecular Mechanisms of Procofactor Activation.J Coagul Disord. 2010 Jul 1;2(2):19-27. J Coagul Disord. 2010. PMID: 21165149 Free PMC article.
-
Genetic sequence analysis of inherited bleeding diseases.Blood. 2013 Nov 14;122(20):3423-31. doi: 10.1182/blood-2013-05-505511. Epub 2013 Oct 11. Blood. 2013. PMID: 24124085 Free PMC article. Review.
-
Dual Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease and Peripheral Artery Disease Patients.Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):726-732. doi: 10.1161/ATVBAHA.117.310048. Epub 2018 Feb 15. Arterioscler Thromb Vasc Biol. 2018. PMID: 29449336 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials